Dr. Sunray Lee embodies the ideal candidate for a Best Researcher Award through his unmatched dedication, multidisciplinary expertise, and leadership in regenerative medicine, stem cell biology, and biomaterials research. With over 20 years of experience and numerous high-impact publications, his work bridges science and innovation, directly contributing to advancements in clinical and cosmetic therapeutics. He has led transformative R&D, mentored scientific communities, and represented Korea in international regenerative medicine collaborations.
🎓 Education
-
B.Sc. in Agronomy – Korea University (1995–1999) 🌾
-
M.Sc. in Molecular & Cellular Immunology – Korea University (2000–2003) 🧫
-
Ph.D. in MHC & Stem Cell Biology – Korea University (2006–2012) 🧬
💼 Professional Experience
-
🔬 Researcher, MHC Lab, Seoul National University (2004–2005)
-
🧪 Senior Scientist, MizMedi Hospital (2005–2007)
-
🧫 Senior Scientist, MCTT Research Institute (2007–2011)
-
🧠 Member, KEIT Innovation Evaluation (2010–2025)
-
🧬 Director, CEFO Research Institute (2012–Present)
-
🔗 Committee Member, KSMCB, KSB, KSSCR, CARM, APACRM (2017–Present)
Professional Development 🚀📖
Dr. Sunray Lee’s professional growth is rooted in cross-disciplinary research, collaborative leadership, and regulatory insight 📚🔬. He is deeply involved in Korea’s R&D planning and policy through KEIT and serves as Vice Chair at CARM’s International Cooperation Committee 🌐🤝. His participation in global forums like APACRM and KSSCR highlights his dedication to regenerative medicine diplomacy 🌱💬. Dr. Lee frequently delivers keynote talks and publishes cutting-edge research in journals spanning biomedical engineering, dermatology, and pharmaceuticals 📖🗣️. He continuously fosters innovation through industry-academia linkages and promotes ethical advancement in biotechnology and stem cell research 🌍⚙️.
Research Focus 🔍🤖
Dr. Lee’s research revolves around regenerative medicine, focusing on stem cell biology, biomaterials, and cellular therapy 🧬🧪. His work includes developing 3D cell culture systems, cryopreservation methods, and stem cell-based skin and bone therapies 🧫🦴. A major emphasis lies in mesenchymal stem cells, pluripotent stem cells, and their therapeutic applications in cosmetics and orthopedics 🧖♀️⚕️. His projects combine bioengineering, molecular biology, and omics to optimize cell culture environments and develop innovative treatment platforms 🔍🔧. With a vision toward translational medicine, he contributes to national and international standards for advanced regenerative products and clinical protocols 🌐🧠.
Awards and Honors 🏆🎖️
-
🏅 Citation by Ministry of Trade, Industry & Energy (MOTIE) – Dec. 12, 2018
-
🥇 Best Investigator Award, Korea University – Mar. 27, 2012
Publications & Citations 📚
-
-
2025 – 🧪 Development of Mold Technology for Insert-Wells
-
2024 – 🧬 Cell Therapy Using Umbilical Cord MSCs for Osteonecrosis
-
2023 – 🦴 Osteogenic-Induced Adipose Stem Cells in Canine Bone Repair
-
2023 – 💧 Stem Cell-Conditioned Medium for Whitening & Moisturizing
-
2023 – 🧫 Tracking HUVECs Using Quantum Dot Nanoparticles
-
2023 – 🌏 Asia Guidelines for Ancillary Materials in Cell Therapy
-
2022 – ❄️ Cryogenic Storage Container Cell Viability Study
-
2022 – 💆 3D Stem Cell Cream Effects on Skin Elasticity
-
2020 – 🌿 Anti-aging Effects of Stem Cell Creams
-
2020 – 🧬 Medroxyprogesterone & Metformin in Endometrial Cancer
-
2020 – ❄️ Cryogenic Container Plastic Changes Analysis
-
2020 – 💊 3D Co-culture to Enhance Drug Selectivity
-
2020 – 🧴 Cosmetic Products with MSC Medium
-
2019 – 🐎 Equine iPSCs for Therapeutic MSC Differentiation
-
2019 – 🛡️ Immune Effects of 3D MSC Conditioned Cream
-
2018 – 💪 Induced Myogenic Stem Cells via Transcription Factors
-
2016 – 💉 Apoptin Gene Delivery for Glioma Cells
-
2016 – 🧬 Glycol Chitosan-PEI Gene Carrier for MSCs
-
2016 – 🧫 PAMAM Dendrimers for Gene Delivery to MSCs
-
2012 – 🧬 DNA Methylation in Pluripotent Stem Cells
-
2011 – 🧪 Stem Cell Substrate Physical Properties
-
2011 – 🦷 Dental Stem Cell Comparisons
-
2011 – 🔁 Dynamic Gene Copy Number Changes in iPSCs
-
2010 – 🧬 Adipogenic Differentiation in Feeder Cells
-
2010 – 🧬 Umbilical MSCs as Therapy
-
2009 – 🦴 MSC Source Phenotypic Analysi
-
2004 – ⚙️ Promyelocytic Leukemia & SAPK2 Inhibition
-
2004 – 🦠 CMV and MHC Class I Immune Evasion
-
2004 – 🛡️ HLA-G Shedding & NK Cell Inhibition
🔍 Conclusion:
Dr. Sunray Lee’s consistent pursuit of excellence, coupled with tangible contributions to science, medicine, and technology, makes him not just a candidate—but a model recipient—for the Best Researcher Award. His innovative mindset, translational achievements, and leadership in stem cell applications mark him as a cornerstone in modern biomedical research 🧠🌱.